Literature DB >> 25180626

Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.

Takahiro Minato1, Mikihiro Tsutsumi1, Mutsumi Tsuchishima1, Nobuhiko Hayashi1, Takashi Saito1, Yasuhiro Matsue1, Nobuyuki Toshikuni1, Tomiyasu Arisawa2, Joseph George1.   

Abstract

The pathogenesis of nonalcoholic steatohepatitis (NASH) is a two-stage process in which steatosis is the "first hit" and an unknown "second hit." We hypothesized that "a binge" could be a "second hit" to develop NASH from obesity-induced simple steatosis. Thirty-week-old male Otsuka Long-Evans Tokushima fatty (OLETF) rats were administered 10 mL of 10% ethanol orally for 5, 3, 2, and 1 d/wk for 3 consecutive weeks. As control, male Otsuka Long-Evans Tokushima (OLET) rats were administered the same amount of alcohol. Various biochemical parameters of obesity, steatosis and NASH were monitored in serum and liver specimens in untreated and ethanol-treated rats. The liver sections were evaluated for histopathological alterations of NASH and stained for cytochrome P-4502E1 (CYP2E1) and 4-hydroxy-nonenal (4-HNE). Simple steatosis, hyperinsulinemia, hyperglycemia, insulin resistance, hypertriglycemia and marked increases in hepatic CYP2E1 and 4-HNE were present in 30-wk-old untreated OLETF rats. Massive steatohepatitis with hepatocyte ballooning was observed in the livers of all OLETF rats treated with ethanol. Serum and hepatic triglyceride levels as well as tumor necrosis factor (TNF)-α mRNA were markedly increased in all ethanol-treated OLETF rats. Staining for CYP2E1 and 4-NHE demonstrated marked increases in the hepatic tissue of all the groups of OLETF rats treated with ethanol compared with OLET rats. Our data demonstrated that "a binge" serves as a "second hit" for development of NASH from obesity-induced simple steatosis through aggravation of oxidative stress. The enhanced levels of CYP2E1 and increased oxidative stress in obesity play a significant role in this process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180626      PMCID: PMC4277551          DOI: 10.2119/molmed.2014.00048

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  49 in total

Review 1.  Metabolic and nutritional considerations in nonalcoholic fatty liver.

Authors:  D G Fong; V Nehra; K D Lindor; A L Buchman
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

2.  M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes.

Authors:  Fataneh Amidi; Barbara A French; David Chung; Charles H Halsted; Valentina Medici; Samuel W French
Journal:  Exp Mol Pathol       Date:  2007-10-25       Impact factor: 3.362

3.  Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.

Authors:  Shinji Tamura; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Induction of cytochrome P450IIE1 in the obese overfed rat.

Authors:  J L Raucy; J M Lasker; J C Kraner; D E Salazar; C S Lieber; G B Corcoran
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

Review 5.  Nonalcoholic fatty liver disease.

Authors:  Z M Younossi
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

Review 6.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

7.  Role of alcohol metabolism in non-alcoholic steatohepatitis.

Authors:  Susan S Baker; Robert D Baker; Wensheng Liu; Norma J Nowak; Lixin Zhu
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

8.  Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM.

Authors:  T Sato; Y Asahi; K Toide; N Nakayama
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

9.  CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.

Authors:  Mohamed A Abdelmegeed; Atrayee Banerjee; Sehwan Jang; Seong-Ho Yoo; Jun-Won Yun; Frank J Gonzalez; Ali Keshavarzian; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2013-09-21       Impact factor: 7.376

10.  Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients.

Authors:  Helma P Cotrim; Luiz Antônio Freitas; Erivaldo Alves; Alessandro Almeida; Daniel S May; Stephen Caldwell
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

View more
  18 in total

Review 1.  Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.

Authors:  Anam Khan; Aylin Tansel; Donna L White; Waleed Tallat Kayani; Shah Bano; Jan Lindsay; Hashem B El-Serag; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-06       Impact factor: 11.382

Review 2.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

4.  Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.

Authors:  Ryuichi Kubota; Nobuhiko Hayashi; Kaori Kinoshita; Takashi Saito; Kazuaki Ozaki; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Joseph George
Journal:  Br J Pharmacol       Date:  2020-10-19       Impact factor: 8.739

Review 5.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

6.  Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.

Authors:  Xue Chen; Emmanuel Owoseni; Julia Salamat; Arthur I Cederbaum; Yongke Lu
Journal:  Arch Biochem Biophys       Date:  2018-09-15       Impact factor: 4.013

7.  The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.

Authors:  Tingting Ren; Juanjuan Zhu; Lili Zhu; Mingliang Cheng
Journal:  Nutrients       Date:  2017-02-27       Impact factor: 5.717

8.  Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo.

Authors:  Simon Bucher; Arnaud Tête; Normand Podechard; Marie Liamin; Dounia Le Guillou; Martine Chevanne; Cédric Coulouarn; Muhammad Imran; Isabelle Gallais; Morgane Fernier; Quentin Hamdaoui; Marie-Anne Robin; Odile Sergent; Bernard Fromenty; Dominique Lagadic-Gossmann
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

9.  Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells.

Authors:  Jason M Correnti; Lauren Gottshall; Annie Lin; Bianca Williams; Amanke Oranu; James Beck; Jie Chen; Michael J Bennett; Rotonya M Carr
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

10.  Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae.

Authors:  Muhammad Imran; Odile Sergent; Arnaud Tête; Isabelle Gallais; Martine Chevanne; Dominique Lagadic-Gossmann; Normand Podechard
Journal:  Biomolecules       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.